Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature

Langerhans cell histiocytosis (LCH) is a diagnostic and therapeutic challenge. We report on a rare case of its primary oral manifestation that was treated successfully with the BRAF-specific agent, vemurafenib, after insufficient standard LCH treatment. This case underlines the importance of proper...

Descripción completa

Detalles Bibliográficos
Autores principales: Neckel, Norbert, Lissat, Andrej, von Stackelberg, Arendt, Thieme, Nadine, Doueiri, Mohemed-Salim, Spors, Birgit, Beck-Broichsitter, Benedicta, Heiland, Max, Raguse, Jan-Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801882/
https://www.ncbi.nlm.nih.gov/pubmed/31666812
http://dx.doi.org/10.1177/1758835919878013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801882/
https://www.ncbi.nlm.nih.gov/pubmed/31666812
http://dx.doi.org/10.1177/1758835919878013

Ejemplares similares